Cysteamine: Clinical efficacy, safety and tolerability versus best-in-class treatments for melasma
Main Article Content
Keywords
cysteamine, melasma
Abstract
N/A
References
2. Chavin, W.; Schlesinger, W. (1966). Some potent melanin depigmentary agents in the black goldfish. Die Naturwissenschaften
53(16): 413–414.
3. Frenk E, Pathak MA, Szabo G, Fitzpatrick TB. (1968). Selective action of mercaptoethylamines on melanocytes in mammalian
skin: experimental depigmentation. Arch Dermatol 97:465–77.
4. Bleehen, S. S., Pathak, M. A., Hori, Y., & Fitzpatrick, T. B. (1968). Depigmentation of skin with 4-isopropylcatechol,
mercaptoamines, and other compounds. J Invest Dermatol, 50(2), 103-117.
5. Qiu L, Zhang M, Sturm RA, Gardiner B, Tonks I, Kay G, Parsons PG. (2000) Inhibition of melanin synthesis by cysteamine in
human melanoma cells. J Invest Dermatol. 114(1):21-7.
6. Atallah, C., Charcosset, C., & Greige-Gerges, H. (2020). Challenges for cysteamine stabilization, quantification, and biological
effects improvement. J Pharm Anal.
7. Mansouri, P.; Farshi, S.; Hashemi, Z.; Kasraee, B. (2015).Evaluation of the efficacy of cysteamine 5% cream in the treatment of
epidermal melasma: a randomized double-blind placebo-controlled trial. Br J Dermatol. 173 (1): 209–217.
8. Farshi, and al. (2017).Efficacy of cysteamine cream in the treatment of epidermal melasma, evaluating by Dermacatch as a
new measurement method: a randomized double-blind placebo-controlled study. J Dermatol Treat, 1–8.
9. Wood, J. M., & Schallreuter, K. U. (1991). Studies on the reactions between human tyrosinase, superoxide anion, hydrogen
peroxide and thiols. Biochim Biophys Acta, 1074(3), 378-385.
10. Sakurai, H.; Yokoyama, A.; Tanaka, H. (1971). Studies on the sulfur-containing chelating agents. XXXI. Catalytic effect of
copper (II) ion to formation of mixed disulfide. Chem. Pharm. Bull. 19, 1416–1423
11. Bottu, G. (1989). The effect of quenchers on the chemiluminescence of luminol and lucigenin. J Biolumin Chemilumin.
12. Crinelli, Rita, et al. (2019). Boosting GSH Using the Co-Drug Approach: I-152, a Conjugate of N-acetyl-cysteine and βmercaptoethylamine. Nutrients 11.6 1291.
13. Publication pending
14. Karrabi, M., and al. (2020). Clinical evaluation of efficacy, safety and tolerability of cysteamine 5% cream in comparison with
modified Kligman’s formula in subjects with epidermal melasma: A randomized, double‐blind clinical trial study. Skin Res and
Technology
15. Karrabi, M., and al. (2020). Clinical evaluation of efficacy and tolerability of cysteamine 5% cream in comparison with
tranexamic acid mesotherapy in subjects with melasma: a single-blind, randomized clinical trial study. Arch of Dermatol Res.
16. Nguyen, J & Rodrigues, M. (2021). Evaluation of the efficacy of cysteamine cream compared to hydroquinone in the treatment
of melasma: A randomised, double‐blinded trial. Aus J Dermatol, 62(1), e41-e46.
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
Creative Commons Attribution (CC BY): lets others distribute and copy the article, to create extracts, abstracts, and other revised versions, adaptations or derivative works of or from an article (such as a translation), to include in a collective work (such as an anthology), to text or data mine the article, even for commercial purposes, as long as they credit the author(s), do not represent the author as endorsing their adaptation of the article, and do not modify the article in such a way as to damage the author's honor or reputation.
Authors retain copyright in their work and license the publisher to publish the content. The publisher is the National Society for Cutaneous Medicine, with production and publishing support provided by OJS, Open Journal Systems,see https://pkp.sfu.
Prior to January 2022, authors transferred copyright to the National Society for Cutaneous Medicine. However, all articles are freely available to anyone in the world. There are no subscription fees, page charges, or article processing charges.